#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Palmo-plantar Erythrodysesthesia caused by Liposome-encapsulated Doxorubicin


Authors: V. Miňovská
Authors‘ workplace: Dermatovenerologická klinika 1. LF UK, VFN Prahapřednosta doc. MUDr. J. Štork, CSc.
Published in: Čes-slov Derm, , 2003, No. 4, p. 159-161
Category:

Overview

Palmo-plantar erythrodysesthesia (PPE) is a relatively frequent manifestation of the side-effectsof chemotherapy in the skin. It has a clear-out clinical picture, non-specific histology and unclearpathogenesis. Its course in patients often calls for modification and sometimes interruption ofotherwise effective chemotherapy. There is no specific treatment, however, there has been describedthe possible application of certain drugs in cases of chemotherapeutics with which the risk of PPEis most often connected (doxorubicin, cytarabin, docetaxel, fluorouracil). The author describesa clinical case of PPE upon application of liposome-encapsulated doxorubicin in a patient sufferingfrom ovarial carcinoma.

Key words:
chemotherapy - doxorubicin - side-effects - erythrodysesthesia

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Dermatology & STDs Paediatric dermatology & STDs
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#